Review article: The immunoregulatory cytokine interleukin-10 - A therapy for Crohn's disease?

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 11, 2001, Pages 1709-1716

  Lindsay, J O ^a   Hodgson, H J F ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; COLITIS; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; GENE THERAPY; GENETIC POLYMORPHISM; HUMAN; IMMUNOREGULATION; INTESTINE MUCOSA; KNOCKOUT MOUSE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

CLINICAL TRIALS; CROHN DISEASE; GENE THERAPY; HUMANS; INTERLEUKIN-10; INTESTINAL MUCOSA; PATIENT SELECTION; POLYMORPHISM, GENETIC; T-LYMPHOCYTES;

EID: 0034777212     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01093.x     Document Type: Review

References (60)

1. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
2. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12
3. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
4. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
5. Interleukin-10
6. Interleukin-10
7. Contact with T cells modulates monocyte IL-10 production: Role of T cell membrane TNF-alpha
8. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
9. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
10. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II major histocompatibility complex expression
11. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function
12. IL-10 inhibits cytokine production by activated macrophages
13. Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10
14. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
15. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes
16. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation
17. Interleukin 10, a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells
18. IL-10, a novel growth cofactor for mature and immature T cells
19. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
20. Suppression of T cell-mediated injury in human gut by interleukin 10: Role of matrix metalloproteinases
21. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease
22. The immunoregulatory role of interleukin-10 in Crohn's disease (CD) cell cultures
23. Interleukin-10-deficient mice develop chronic enterocolitis
24. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses
25. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice
26. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice
27. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism
28. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice
29. Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells
30. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice
31. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB (low) CD4+ T cells
32. An essential role for interleukin 1O in the function of regulatory T cells that inhibit intestinal inflammation
33. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
34. Role of interleukin-10 in a murine model of dextran sulfate sodium-induced colitis
35. Anti-inflammatory properties of interleukin-10 administration in hapten-induced colitis
36. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells
37. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease
38. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
39. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
40. Interleukin-10 and the interleukin-10 receptor
41. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
42. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease
43. Genetics of inflammatory bowel disease
44. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases
45. A polymorphic dinucleotide repeat in the human IL-10 promoter
46. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence
47. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility
48. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease
49. Anti- and pro-inflammatory effects of interleukin-10 in mild to moderate Crohn's disease
50. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
51. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis
52. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws
53. Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure
54. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
55. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo
56. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
57. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
58. TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung
59. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration
60. Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody